Obesity is a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer

byPublic Library of ScienceObesity is associated with a three-fold increased risk of cardiotoxicity in chemotherapy-treated patients with early-stage breast cancer, regardless of other predictor

Updated on: December 22,2023 17

Obesity is a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer

byPublic Library of ScienceObesity is associated with a three-fold increased risk of cardiotoxicity in chemotherapy-treated patients with early-stage breast cancer, regardless of other predictor

Updated on:December 22,2023 17

Venetoclax/Atezolizumab/Obinutuzumab Elicits Durable Responses in Richter Transformation

June 23, 2023Ryan ScottThe combination of venetoclax, atezolizumab, and obinutuzumab elicited responses and prolonged time progression, in patients with chronic lymphocytic leukemia with Richter trans

Updated on: October 15,2023 76

Venetoclax/Atezolizumab/Obinutuzumab Elicits Durable Responses in Richter Transformation

June 23, 2023Ryan ScottThe combination of venetoclax, atezolizumab, and obinutuzumab elicited responses and prolonged time progression, in patients with chronic lymphocytic leukemia with Richter trans

Updated on:October 15,2023 76

Olaparib maintenance extends PFS by estimated three years in advanced ovarian cancer

byEuropean Society for Medical OncologyTwo-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial, unprecedented improvement in pro

Updated on: December 18,2023 13

Olaparib maintenance extends PFS by estimated three years in advanced ovarian cancer

byEuropean Society for Medical OncologyTwo-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial, unprecedented improvement in pro

Updated on:December 18,2023 13

Ultrafine particles can change defense against lung cancer

by Graciela Gutierrez,Baylor College of MedicinenCB accelerates NSCLC development and metastasis in mice. (A) Schematic diagram of nCB exposure in Pts4d/dmice. Three-month-old Pts4d/d&nbsp

Updated on: December 19,2023 8

Ultrafine particles can change defense against lung cancer

by Graciela Gutierrez,Baylor College of MedicinenCB accelerates NSCLC development and metastasis in mice. (A) Schematic diagram of nCB exposure in Pts4d/dmice. Three-month-old Pts4d/d&nbsp

Updated on:December 19,2023 8

Viewpoint: FDA needs to ensure that information on dense breast notifications are clear and understandable to all

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainYou are among the women who dutifully gets an annual mammogram. Year after year, the results are "normal." But af

Updated on: December 23,2023 10

Viewpoint: FDA needs to ensure that information on dense breast notifications are clear and understandable to all

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainYou are among the women who dutifully gets an annual mammogram. Year after year, the results are "normal." But af

Updated on:December 23,2023 10

New mechanism of radioresistance formation shown in lung adenocarcinoma

by Zhang Nannan,Chinese Academy of SciencesGOLPH3 mediates radioresistance formation of lung adenocarcinoma. Credit: Kong PeizhongA research team led by Prof. Han Wei from the Hefei Institutes o

Updated on: December 22,2023 6

New mechanism of radioresistance formation shown in lung adenocarcinoma

by Zhang Nannan,Chinese Academy of SciencesGOLPH3 mediates radioresistance formation of lung adenocarcinoma. Credit: Kong PeizhongA research team led by Prof. Han Wei from the Hefei Institutes o

Updated on:December 22,2023 6

AstraZeneca to Discontinue Moxetumomab Pasudotox in US for Hairy Cell Leukemia

January 13, 2023Chris RyanMoxetumomab pasudotox-tdfk will be permanently discontinued in the United States market for the treatment of relapsed/refractory hairy cell leukemia.Hairy Cell Leukemia (Kate

Updated on: October 15,2023 168

AstraZeneca to Discontinue Moxetumomab Pasudotox in US for Hairy Cell Leukemia

January 13, 2023Chris RyanMoxetumomab pasudotox-tdfk will be permanently discontinued in the United States market for the treatment of relapsed/refractory hairy cell leukemia.Hairy Cell Leukemia (Kate

Updated on:October 15,2023 168

Localizing BRCA gene mutations to better treat ovarian cancer

byUniversity of GenevaDistribution of mutations in BRCA1 and BRCA2. A. Graphical summary of BRCA1 and BRCA2 mutations. Mutation plot was generated using cBioPortal MutationMapper tool. Black = n

Updated on: December 20,2023 10

Localizing BRCA gene mutations to better treat ovarian cancer

byUniversity of GenevaDistribution of mutations in BRCA1 and BRCA2. A. Graphical summary of BRCA1 and BRCA2 mutations. Mutation plot was generated using cBioPortal MutationMapper tool. Black = n

Updated on:December 20,2023 10

BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma

byPerelman School of Medicine at the University of PennsylvaniaMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0An experim

Updated on: December 22,2023 24

BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma

byPerelman School of Medicine at the University of PennsylvaniaMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0An experim

Updated on:December 22,2023 24

Old drugs offer new ways of treating bowel cancer

byUniversity of AucklandCredit: CC0 Public DomainOld medicines, combined in new ways, are showing promise for treating bowel cancer, a group of University of Auckland researchers has found.&quot

Updated on: December 26,2023 12

Old drugs offer new ways of treating bowel cancer

byUniversity of AucklandCredit: CC0 Public DomainOld medicines, combined in new ways, are showing promise for treating bowel cancer, a group of University of Auckland researchers has found.&quot

Updated on:December 26,2023 12

Access to Medicare increases cancer detection, reduces cancer mortality rate

by Andrew Hellpap,University of Wisconsin-MadisonCredit: CC0 Public DomainAccess to Medicare significantly impacts detection of certain cancers and life expectancy following cancer diagnosis, ac

Updated on: December 20,2023 23

Access to Medicare increases cancer detection, reduces cancer mortality rate

by Andrew Hellpap,University of Wisconsin-MadisonCredit: CC0 Public DomainAccess to Medicare significantly impacts detection of certain cancers and life expectancy following cancer diagnosis, ac

Updated on:December 20,2023 23

Nine common questions about genetic testing for cancer

by Dan Lea,Mayo ClinicCredit: Pixabay/CC0 Public DomainYour genes play a role in nearly all areas of your health. A gene is like an instruction manual for your body that tells your body how to f

Updated on: December 22,2023 10

Nine common questions about genetic testing for cancer

by Dan Lea,Mayo ClinicCredit: Pixabay/CC0 Public DomainYour genes play a role in nearly all areas of your health. A gene is like an instruction manual for your body that tells your body how to f

Updated on:December 22,2023 10